Russia's second vaccine

The Vector State Research Centre of Virology and Biotechnology, a Siberian institute. A second Russian Covic-19 vaccine is on the way which 'avoids the side-effects of the first one' launched in a blaze of publicity by Vladimir Putin this month. The new drug is from a former top-secret Soviet biological weapons research plant in Siberia, now a world-leading virology institute. The second vaccine named EpiVacCorona will be completed in September and 57 volunteers who were used as human guinea-pigs report no side-effects, say scientists.